[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial. - Baudin E; Durand A; Beron A; Smith D; Déandreis D; Taieb D; Ansquer C; Dierickx L; Deshayes E; Hentic O; Moalla S; Menu Y; et al. (The Lancet. Oncology, 2026)